Executives from two ag biotech companies that raised major funding in 2017 shared some of their success secrets to a group of North Carolina peers this week.
NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
September 27, 2017
Foundation Medicine, a Cambridge, Massachusetts firm selling genomic cancer tests, opened a precision health laboratory in Morrisville last year that it is growing into a major facility.
September 20, 2017
The successes expected from CRISPR-Cas systems “Will come first in agriculture,” said North Carolina University food scientist, Rodolphe Barrangou, Ph.D., at the 8th annual NU-Tech Roundtable.
September 20, 2017
Triangle Business Journal’s latest annual roundup of the 50 fastest-growing private companies in the Triangle region includes two bioscience companies and seven others that provide valuable life science support functions.
September 20, 2017
Executives from two ag biotech companies that raised north of $20 million in capital recently will offer their insights on “Secrets for Raising Capital to Build Startups” at the AgBiotech Professional Forum September 27 at the North Carolina Biotechnology Center.
September 19, 2017
Dignify Therapeutics, a drug development company focused on restoring bladder and bowel control for the elderly and for people with spinal injury, multiple sclerosis or diabetes, continues to draw federal grants from the National Institutes of Health for its research and development.
September 19, 2017
The next five years will see more dynamic changes in agriculture technology than seen in the last 25 years, said John Dombrosky, CEO of the Ag Tech Accelerator at the 8th annual NU Tech Roundtable.
September 18, 2017
The North Carolina Biotechnology Center is hosting the second annual VaccinatioNCelebration flu shot clinic all day Tuesday, Oct. 17, 2017, to highlight North Carolinians’ production of the newest generation of flu vaccine.
September 11, 2017
Duke University scientist Philip Benfey, Ph.D., has co-founded his second startup company, Durham-based Hi Fidelity Genetics, to use data on roots to breed and sell corn seed with desirable traits.
September 11, 2017
BioreclamationIVT, a New York company that sells biospecimens and related services, primarily for drug safety testing, has purchased Durham’s Qualyst Transporter Solutions for an undisclosed sum.
September 7, 2017
Raleigh-based Innovate Biopharmaceuticals has received U.S. Food and Drug Administration orphan drug designation for an experimental oral drug to treat pediatric ulcerative colitis.
September 6, 2017
Jack Bailey, president of U.S. Pharmaceuticals for GlaxoSmithKline, says an internship he served at the Biotech Center was a major influence in his successful career as a global pharmaceutical company leader.
September 5, 2017
Durham-based Bioventus, a global orthobiologics company, has received approval from the U.S. Food and Drug Administration to market Durolane, a single-injection joint lubricant for treating pain from knee osteoarthritis.
August 30, 2017
Sixteen life science companies throughout North Carolina have received just over $1 million in grants from a state program to support their development of new technologies and products.